Thompson Street Capital Partners Portfolio Company Isto Biologics Acquires Theracell
Acquiring Company
Isto Biologics
Acquired Company
TheraCell
HopkintonManufacturingManufacturingSoftwareMedia And EntertainmentDescription
Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced its portfolio company Isto Biologics, a leader in surgical-based, osteo-biologic regeneration technologies and cell-based therapies, has acquired TheraCell, Inc., a California-based regenerative medicine company. The acquisition will strengthen Isto’s focus on offering extraordinary solutions for surgical and clinical care procedures within spine, orthopedics, and sports medicine. Terms of the transaction were not disclosed.
Quick answer
Isto Biologics is acquiring TheraCell, announced April 5, 2022. Isto Biologics is based in Hopkinton, Massachusetts, United States.
- How much did Isto Biologics pay for TheraCell?
- The deal value was not disclosed.
- What does Isto Biologics do?
- Isto Biologics is a leading biologic and cellular therapy company in the orthopedic space.
- Where are Isto Biologics and TheraCell based?
- Isto Biologics is based in Hopkinton, Massachusetts, United States.
- Who are the decision-makers at Isto Biologics?
- Fundz holds 1 contact at Isto Biologics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Media And Entertainment and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Leading Autodesk Advanced Manufacturing Gold Solution Provider Dsi Acquires Silverhawk Solutions To Better Serve Autodesk Fusion 360 Users In The Usa And Canada (May 9, 2022)
- Seacoast Announces The Acquisition Of Drummond Banking Company (May 4, 2022)
- Clubspeed Acquires Resova To Extend Leadership In Escape Rooms And Activity & Tour Operator Markets (April 14, 2022)
- Nivel Parts & Manufacturing Acquires Epi Performance (April 13, 2022)
- Candle Media Acquires Attn: (May 17, 2022)
- Gofundme Completes Acquisition Of Classy (May 17, 2022)
Who to call at Isto Biologics, and when
When Isto Biologics changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Isto Biologics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Isto Biologics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Isto Biologics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Isto Biologics makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired TheraCell?
TheraCell was acquired by Isto Biologics, based in Hopkinton. The deal was reported on April 5, 2022. Isto Biologics is a leading biologic and cellular therapy company in the orthopedic space. Isto Biologics is privately held and operates in Manufacturing.
When did Isto Biologics acquire TheraCell?
Isto Biologics's acquisition of TheraCell was reported on April 5, 2022. Thompson Street Capital Partners (TSCP), a private equity firm based in St. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does TheraCell do?
TheraCell is focused on the development of advanced technologies for bone and soft tissue repair and is the inventor of the next-generation, TheraFuze DBF® demineralized bone fiber technology. It is privately held, operating in Manufacturing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.